Minova Labs is excited to announce the release of our new Expanded Cannabinoid Potency Panel. This innovative methodology allows us to quantify a wide range of novel cannabinoid analytes, providing even more comprehensive testing services to our clients in the cannabis industry.
The Importance of Expanded Cannabinoid Potency Panel Testing
Cannabinoid potency testing provides consumers with information regarding the cannabinoid content of the products they are using. Potency analysis measures the levels of various cannabinoids present in the product. This information is useful for individuals to determine the appropriate dosage for consumption, as well as the potential effects of the cannabis product once consumed. Additionally, cannabinoid potency testing can help ensure that the cannabis products being sold are accurately labeled, providing assurance to the consumer that the product quality is representative to the label claim. Overall, cannabinoid potency testing is crucial to ensure the safety and efficacy of manufactured products satisfies consumer expectations and regulatory requirements.
Exploring What Makes This Method Unique
Cannabinoids analyzed in the Expanded Cannabinoid Panel are novel cannabinoids recently emerging in the industry. This method analyzes a wide range of cannabinoids that are naturally occurring but also can be synthetically produced. These cannabinoids tend to have more psychoactive properties than the analyte list found in other potency testing methods. Considering the effects of these cannabinoids, there is an urgent need for quality lab testing for these products and limited testing facilities with the capabilities to analyze them.
Due to the unique properties and recent emergence, understanding the potency of these cannabinoids is crucial for all consumers and manufacturers. The analytes in the Expanded Cannabinoid Panel test for many acetates, homologs, isomers, and derivatives. Isomers are compounds that have the same chemical formula but differ in the arrangement of their atoms. Analogues are compounds that have a similar chemical structure to another compound, but with some slight differences. Derivatives are compounds that are derived from another compound through chemical modification.
Overall, a key difference between this method and general potency methods is the novel cannabinoids analyzed and the unique effects they can offer. It is important to be aware of the unique properties and potential effects of psychoactive cannabinoids, as well as their dosage and the various forms in which they can be consumed.
The Expanded Cannabinoid Panel tests the following analytes:
Δ8-Tetrahydrocannabinol Acetate (Δ8-THC-O Acetate)
Δ9-Tetrahydrocannabinol Acetate (Δ9-THC-O Acetate)
Minova: Ensuring the Quality and Safety of your products through Comprehensive Lab Testing for Novel Cannabinoids
At Minova, our mission is to provide the highest quality lab services for the alternative medicine industry. We strive to be ahead of the industry by providing our customers novel testing for novel analytes. Our state-of-the-art lab is dedicated to ensuring accuracy, reliability, and transparency in our testing processes. We are dedicated to helping ensure the safety and quality of consumer products, and this additional analysis is just one of the many ways we are working to support you and your business.